Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 177
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00011973 | Chemotherapy in Treating Patients With Advanced Kidney Cancer | ||
| NCT05556473 | F-Tryptophan PET/CT in Human Cancers | ||
| NCT00014573 | Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer | ||
| NCT00005027 | Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer | ||
| NCT03683420 | Music in Reducing Distress in Participants with Cancer During Chemotherapy Treatment | ||
| NCT00030420 | Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer | ||
| NCT00248482 | Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer | ||
| NCT00003626 | Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy | ||
| NCT00618826 | A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer | ||
| NCT02620865 | BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer | ||
| NCT00899665 | Proteases in Patients With Prostate Cancer That Has Spread to the Bone | ||
| NCT01420874 | Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) | ||
| NCT00003174 | Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia | ||
| NCT03676920 | Feasibility and Utilization of an Application-based Question Prompt List | ||
| NCT00003220 | Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer | ||
| NCT02960594 | hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse | ||
| NCT02824029 | Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma | ||
| NCT00004144 | Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer | ||
| NCT06501040 | Increasing Knowledge and Interest in Cancer Clinical Trials | ||
| NCT03328091 | Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen) | ||
| NCT00120029 | Peer Counseling for Weight Loss | ||
| NCT03453489 | AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm | ||
| NCT01415089 | Tailored Web-Based Intervention for Cancer Patients and Family Caregivers | ||
| NCT00897494 | Identification of Biomarkers for Early Detection of Pancreatic Cancer | ||
| NCT00238329 | PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma | ||
| NCT00499694 | Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel | ||
| NCT00960427 | Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | ||
| NCT04479267 | Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma | ||
| NCT00482846 | Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma | ||
| NCT00248560 | Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer | ||
| NCT02269267 | The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) | ||
| NCT00066326 | Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia | ||
| NCT03091257 | A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma | ||
| NCT00376948 | Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | ||
| NCT00258466 | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer | ||
| NCT00028548 | XK469 in Treating Patients With Advanced Solid Tumors | ||
| NCT00243048 | Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer | ||
| NCT05025748 | Ask Questions (ASQ):Implementation of a Communication Intervention | ||
| NCT00003925 | Combination Chemotherapy In Treating Patients With Advanced Cancer | ||
| NCT00423826 | Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease | ||
| NCT00938626 | Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma | ||
| NCT00020722 | Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer | ||
| NCT00918762 | Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx | ||
| NCT00303901 | Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | ||
| NCT00520767 | Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease | ||
| NCT01208662 | Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 | ||
| NCT04037462 | Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy | ||
| NCT03454529 | The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer | ||
| NCT01270880 | Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy | ||
| NCT05903092 | MOnaliZumab in Combination with DurvAlumab (MEDI4736) Plus Platinum-based ChemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer |
